Malignant Melanoma and Beyond: An introduction to Targeted Treatments and Cancer Immunotherapy
Description: 1-day course describing the recent advances made in targeted treatments for cancer, using malignant melanoma as the primary example. Delegates will learn about the faulty genes, pathways and proteins that drive malignant melanoma and other solid tumours, and the mechanism of action of targeted treatments such as B-Raf inhibitors and MEK inhibitors. The day also includes an overview of immunotherapy approaches for cancer, including T cell-based treatments and checkpoint inhibitors.
Audience: Ideal for research nurses, clinical nurse specialists, administrative staff, clinical trials coordinators
To book, contact: email@example.com or call: 020 7808 2922
View the programme